LISAvienna: First newsletter for 2024 available online

Today we are highlighting news from selected companies and research institutions, including Biomay, Danaher, G.ST Antivirals, CCRI, CeMM; MADx, UpNano, MedUni Vienna, SIMCharacters, Bio&Bio, cubicure and Vivaldi Biosciences.

We also provide information about funding opportunities and events such as BIO-Europe Spring, where we organize the LISA joint booth and where there are still some remaining LISA packages, as well as The MedTech Forum 2024 in Vienna, where LISAvienna is active as host organization together with Austromed, and HIMMS, where we invite participants from Austria to a joint lunch in the conference center.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.